MRI Helps Decisions on Lateral Nodal Disease in Rectal Cancer MRI Helps Decisions on Lateral Nodal Disease in Rectal Cancer
Primary and restaging MRI can help define the risk of lateral local recurrence - and the need for lateral lymph node dissection (LLND) - in patients with low rectal cancer after chemoradiotherapy or radiotherapy, according to a multinational study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news
' Pick the Winner' Trial in Rectal Cancer: Chemoradiation First'Pick the Winner' Trial in Rectal Cancer: Chemoradiation First
A ' pick the winner ' trial found that chemoradiation followed by chemo wins in total neoadjuvant therapy for locally advanced rectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 5, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
NRG trial suggests total neoadjuvant therapy for locally advanced rectal cancer is safe
(NRG Oncology) Results from the first experimental arm using veliparib as part of total neoadjuvant therapy (induction chemotherapy followed by chemoradiotherapy and surgery; TNT) in patients with locally advanced rectal adenocarcinoma on the NRG Oncology Phase II clinical trial NRG-GI002 were recently presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2019 Category: Cancer & Oncology Source Type: news
The Lancet Gastroenterology & Hepatology: Colorectal cancer incidence on the rise among young adults in several high-income countries
(The Lancet) The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a decline or stabilisation trend in the incidence of colorectal cancers within the overall populations of high-income countries. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news
Watch and Wait in Rectal Cancer: Who's In and Who's Out? Watch and Wait in Rectal Cancer: Who's In and Who's Out?
The standard surgical approach for low-lying rectal cancer can result in significant morbidity. Is a non-surgical approach potentially effective?Journal of Oncology Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Nonoperative Management May Be Possible for Select Patients With Rectal Cancer
Researchers evaluated a “watch and wait” strategy that includes chemotherapy and radiation, but not surgery, in carefully selected patients with rectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 26, 2019 Category: Cancer & Oncology Authors: John Schieszer Source Type: news
Kenya: Shortage of Critical Waste Bags Worsens Agony of Patients
[Nation] Peter was diagnosed with rectal cancer in 2016 and went through chemotherapy and radiotherapy. The disease recurred in 2017 and he had to have his rectum removed. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 23, 2019 Category: African Health Source Type: news
MRI Identifies Rectal-Cancer Patients Suitable for Primary Surgery MRI Identifies Rectal-Cancer Patients Suitable for Primary Surgery
MRI criteria can be used to identify"good prognosis" rectal-cancer patients for primary surgery (without chemoradiotherapy first), according to results from the QuickSilver clinical trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
UCLA researchers study cost-effectiveness of rectal cancer treatments
Costs are on the rise for many kinds of medical treatments. UCLA researchers are looking for cost-effective ways to treat people who have locally advanced rectal cancer, a cancer located in the end section of the large intestine.“There is a pressing need for cost-effectiveness studies within the field of radiation oncology,” said Dr. Ann Raldow, the study’s first author and a member of the UCLA Jonsson Comprehensive Cancer Center. “As our treatments become more technical and expensive, it is our responsibility to pr ove that these treatments lead to benefits that warrant the increased cost and that limited resource...
Source: UCLA Newsroom: Health Sciences - April 12, 2019 Category: Universities & Medical Training Source Type: news
Complications After Colectomy: Does Procedure Type Matter? Complications After Colectomy: Does Procedure Type Matter?
Dr Lowenfels comments on a study comparing hernia and bowel obstruction rates of laparoscopic versus open surgery for rectal cancer.Medscape General Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 3, 2019 Category: Consumer Health News Tags: General Surgery Viewpoint Source Type: news
Triple drug treatment beats bowel cancer resistance
And researchers say combination therapy could also attack other cancers Related items fromOnMedica Faecal blood testing best to spot cancer and cost-effective Cetuximab with chemo shrinks more secondaries Benefits of aspirin to treat bowel cancer Surgery after radiation therapy effective for rectal cancer Invest in workforce to roll out bowel cancer screening, urges former health secretary (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 24, 2019 Category: UK Health Source Type: news
URMC Recognized by American College of Surgeons National Accreditation Program for Rectal Cancer
URMC is only the sixth institution in the country and the only one in New York and the Northeast to receive this accreditation so far. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - March 20, 2019 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news
Solving the 'Catch 22' of rectal cancer
(Champalimaud Centre for the Unknown) When rectal cancer infiltrates lymph nodes, patients may have better clinical outcome if chemo/radiotherapy are administered before surgery. However, the lymph nodes' status can only be precisely assessed upon removal during this same surgery. To find a way out of this 'Catch,' a multidisciplinary team, developed an MRI methodology, called SPI, that identifies infiltrated lymph nodes. SPI can help define treatment strategy for rectal cancer patients and may have future implications for other malignancies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2019 Category: Cancer & Oncology Source Type: news
New center addresses alarming increase in colorectal cancer rates among young adults
The Young-Onset Colorectal Cancer Center is among the first centers in the country dedicated to treating colon and rectal cancer patients under age 50 (Source: BWH News)
Source: BWH News - March 5, 2019 Category: Hospital Management Source Type: news
Outcomes Following Pelvic Exenteration for Rectal Cancer Outcomes Following Pelvic Exenteration for Rectal Cancer
Data from an international collaboration provides insight into the outcomes and prognosis of patients who have undergone pelvic exenteration for rectal cancer.Annals of Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 19, 2019 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
